Track the AstraZeneca PLC share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, AstraZeneca PLC has logged 9 reports. Market capitalisation: €222.8bn. The latest transaction was filed on 8 July 2026 (Attribution). Among the most active insiders: Sharma Mani. The full history is openly available.
9
Insider Decl.
0
Thresholds
€735
2 ops.
Buy Volume
€1m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AstraZeneca PLC Buy (bullish), based on 22 analysts. Average price target: £16,243.61.
39Σ signal
Buys €735€1m Sells
Fundamental score
Ranked 4,183 of 25,936 companies
69.2
score / 100
Value
57
Quality
81
FCF yld4.2%
Earn yld4.9%
EV/EBITDA12.1x
ROE23%
Gross mgn82%
Net mgn17%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
9.074 shares@ €81.04990.0000% mcap100.0% of flowDepåbevisFI:A003S640-1
Ideal exit: 6 Jun 2026 (T+270)
9 of 9 declarations
About AstraZeneca PLC
AstraZeneca PLC is a global pharmaceutical company focused on the research, development, and commercialization of drugs in the fields of oncology, cardiovascular, and respiratory diseases. It is listed on the Stockholm Stock Exchange under the symbol XSTO.